BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18613897)

  • 1. Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement.
    Lobo T; Morgan J; Bjorksten A; Nicholls K; Grigg L; Centra E; Becker G
    Intern Med J; 2008 Jun; 38(6):407-14. PubMed ID: 18613897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
    Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
    Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiopulmonary exercise capacity increases after interventional ASD-closure].
    Weber M; Neumann T; Rau M; Brandt R; Dill T; Maikowski C; Mitrovic V; Hamm C
    Z Kardiol; 2004 Mar; 93(3):209-15. PubMed ID: 15024588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients.
    Agostoni P; Emdin M; Corrà U; Veglia F; Magrì D; Tedesco CC; Berton E; Passino C; Bertella E; Re F; Mezzani A; Belardinelli R; Colombo C; La Gioia R; Vicenzi M; Giannoni A; Scrutinio D; Giannuzzi P; Tondo C; Di Lenarda A; Sinagra G; Piepoli MF; Guazzi M
    Eur Heart J; 2008 Oct; 29(19):2367-72. PubMed ID: 18682448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus.
    Carvalho MR; Sato EI; Tebexreni AS; Heidecher RT; Schenkman S; Neto TL
    Arthritis Rheum; 2005 Dec; 53(6):838-44. PubMed ID: 16342102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients.
    Carvalho VO; Ruiz MA; Bocchi EA; Carvalho VO; Guimarães GV
    Cardiol J; 2009; 16(5):426-31. PubMed ID: 19753521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.
    Guazzi M; Dickstein K; Vicenzi M; Arena R
    Circ Heart Fail; 2009 Nov; 2(6):549-55. PubMed ID: 19919979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise capacity of a contemporary cohort of children with hypoplastic left heart syndrome after staged palliation.
    Möller P; Weitz M; Jensen KO; Dubowy KO; Furck AK; Scheewe J; Kramer HH; Uebing A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):980-5. PubMed ID: 19643621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of exercise training heart rate in patients on beta-blockers after myocardial infarction.
    Tabet JY; Meurin P; Ben Driss A; Thabut G; Weber H; Renaud N; Odjinkem N; Solal AC
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):538-43. PubMed ID: 16874142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
    J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease.
    Niedeggen A; Skobel E; Haager P; Lepper W; Mühler E; Franke A
    Cardiol Young; 2005 Aug; 15(4):385-90. PubMed ID: 16014186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rate-adaptive atrial pacing versus ventricular backup pacing on exercise capacity in patients with left ventricular dysfunction.
    Passman R; Banthia S; Galvez D; Sheldon T; Kadish A
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):1-6. PubMed ID: 19140906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome?
    Frigiola A; Tsang V; Bull C; Coats L; Khambadkone S; Derrick G; Mist B; Walker F; van Doorn C; Bonhoeffer P; Taylor AM
    Circulation; 2008 Sep; 118(14 Suppl):S182-90. PubMed ID: 18824753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary exercise testing in Fabry disease.
    Bierer G; Kamangar N; Balfe D; Wilcox WR; Mosenifar Z
    Respiration; 2005; 72(5):504-11. PubMed ID: 16210890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of heart rate during exercise for response to cardiac resynchronization therapy.
    Maass AH; Buck S; Nieuwland W; Brügemann J; van Veldhuisen DJ; Van Gelder IC
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):773-80. PubMed ID: 19207785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerobic capacity is associated with 100-day outcome after hepatic transplantation.
    Epstein SK; Freeman RB; Khayat A; Unterborn JN; Pratt DS; Kaplan MM
    Liver Transpl; 2004 Mar; 10(3):418-24. PubMed ID: 15004771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac performance during exercise in patients with Fabry's disease.
    Spinelli L; Nicolai E; Acampa W; Imbriaco M; Pisani A; Rao MA; Scopacasa F; Cianciaruso B; De Luca N; Cuocolo A
    Eur J Clin Invest; 2008 Dec; 38(12):910-7. PubMed ID: 19021715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.